The Aging Research Center (ARC), established in 2000 by Karolinska Institutet (KI) and Stockholm University (SU), is internationally renowned for its research on the health status of older adults, trends and inequality among older people, brain aging, and prevention of dementia. Research conducted at ARC is based on data from several large-scale ongoing and completed longitudinal studies (local, national and international), national registers, and from experimental and intervention studies conducted on a smaller scale.
KI, where ARC is located, is one of the world’s foremost medical universities. Research at KI spans the entire medical field, from basic experimental research to patient-oriented and nursing research. It is Sweden’s single largest centre of medical academic research and offers the country’s widest range of medical courses and programmes. KI has collaboration agreements in research and education with a large number of universities the world over, with companies in the biomed and biotech sectors and also with individual countries.
The scientists involved in AFFIRMO make up a multidisciplinary team that will bring to the project its expertise is geriatric medicine, epidemiology of aging, neuroepidemiology, clinical pharmacology, and biostatistics. The group has an extensive experience in running observational studies, based on longitudinal population-based data, in the field of multimorbidity, geriatric syndromes, frailty, dementia, cardiovascular risk factors and quality of pharmacological prescription. The group will lead WP3 and will contribute to accomplish the specific objectives planned in WP3 and WP4.